Quotes Regen BioPharma, Inc. OTC Markets
Equities
RGBPP
US75886M4096
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.5 USD | +48.51% | 0.00% | -36.40% |
Quotes 5-day view
Delayed Quote OTC Markets17/06/2024 | |
---|---|
Last | 1.5 $ |
Volume | 946 |
Change | +∞% |
Opening | 1.20 |
High | 1.50 |
Low | 1.20 |
Performance
1 day | +48.51% | ||
Current month | -11.11% | ||
1 month | +47.06% | ||
3 months | -25.74% | ||
6 months | -36.40% | ||
Current year | -36.40% | ||
1 year | -64.79% | ||
3 years | -98.13% | ||
5 years | -93.33% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Bio Therapeutic Drugs
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
+48.51% | 0.00% | -36.40% | -64.79% | 2.92M | ||
+0.04% | +1.44% | +16.49% | +36.42% | 122B | ||
-0.19% | +2.89% | +21.73% | +36.31% | 115B | ||
+0.12% | +17.15% | +22.33% | +21.27% | 26.64B | ||
-2.20% | -4.35% | -21.81% | -22.83% | 19.91B | ||
+0.18% | -0.11% | -16.71% | -29.72% | 16.32B | ||
-3.01% | -5.34% | -18.81% | -18.69% | 15.49B | ||
-0.69% | -4.12% | -44.74% | -37.28% | 15.52B | ||
-0.73% | +33.52% | +62.72% | +44.91% | 14.83B | ||
+0.56% | +3.80% | +3.09% | +41.36% | 13.67B | ||
-1.05% | +5.18% | +122.59% | +246.46% | 11.12B | ||
+0.74% | +3.88% | +19.51% | +51.77% | 8.17B | ||
-0.92% | +32.46% | +129.64% | +252.10% | 7.79B | ||
+3.15% | +10.89% | -25.39% | -37.96% | 8.18B | ||
-2.31% | +7.68% | +5.32% | +53.18% | 7.61B | ||
-1.52% | -6.91% | -8.11% | +20.17% | 7.1B | ||
Average | +2.54% | +6.93% | +14.47% | +37.04% | ||
Weighted average by Cap. | -0.32% | +4.46% | +16.36% | +34.14% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -36.40% | ||
2023 | -92.14% | ||
2022 | -60.00% | ||
2021 | +1,336.78% | ||
2020 | +16.00% | ||
2019 | -28.57% | ||
2018 | -91.60% | ||
2017 | -23.02% | ||
2016 | -74.02% |
- Stock Market
- Equities
- RGBP Stock
- RGBPP Stock
- Quotes Regen BioPharma, Inc.